Detalhe da pesquisa
1.
Rethinking neurodegenerative diseases: neurometabolic concept linking lipid oxidation to diseases in the central nervous system.
Neural Regen Res
; 19(7): 1437-1445, 2024 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38051885
2.
Inhibition of carnitine palmitoyl-transferase 1 is a potential target in a mouse model of Parkinson's disease.
NPJ Parkinsons Dis
; 9(1): 6, 2023 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36681683
3.
Neuroprotective Effect of Sonic Hedgehog Mediated PI3K/AKT Pathway in Amyotrophic Lateral Sclerosis Model Mice.
Mol Neurobiol
; 59(11): 6971-6982, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36056982
4.
Downregulating carnitine palmitoyl transferase 1 affects disease progression in the SOD1 G93A mouse model of ALS.
Commun Biol
; 4(1): 509, 2021 04 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33931719
5.
Pharmacological inhibition of carnitine palmitoyl transferase 1 inhibits and reverses experimental autoimmune encephalitis in rodents.
PLoS One
; 15(6): e0234493, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32520953
6.
Dysregulation of metabolic pathways by carnitine palmitoyl-transferase 1 plays a key role in central nervous system disorders: experimental evidence based on animal models.
Sci Rep
; 10(1): 15583, 2020 09 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32973137
7.
CPT1A plays a key role in the development and treatment of multiple sclerosis and experimental autoimmune encephalomyelitis.
Sci Rep
; 9(1): 13299, 2019 09 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31527712